Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mouse model of multiple sulfatase deficiency
Vi Pham(The University of Texas Health Science Center at Houston), Rebecca C. Ahrens‐Nicklas(Children's Hospital of Philadelphia)
Cited by 3
Related Papers
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
|New England Journal of Medicine|2025|272
Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States
|Cytotherapy|2024|25
The variability of <scp><i>SMARCA4</i></scp>‐related <scp>Coffin–Siris</scp> syndrome: Do nonsense candidate variants add to milder phenotypes?
|American Journal of Medical Genetics Part A|2020|23
KOLF2.1J iPSCs carry CNVs associated with neurodevelopmental disorders
|Cell stem cell|2024|18
A novel iPSC model reveals selective vulnerability of neurons in multiple sulfatase deficiency
|Molecular Genetics and Metabolism|2023|7